tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Olema Oncology price target raised to $38 from $26 at Goldman Sachs
PremiumThe FlyOlema Oncology price target raised to $38 from $26 at Goldman Sachs
8d ago
Promising Potential of Olema Pharmaceuticals’ Palazestrant in Transforming ER+/HER2- Breast Cancer Treatment
Premium
Ratings
Promising Potential of Olema Pharmaceuticals’ Palazestrant in Transforming ER+/HER2- Breast Cancer Treatment
8d ago
Positive Outlook for Olema’s OPERA-02 Trial Based on Roche’s Promising Giredestrant Data
Premium
Ratings
Positive Outlook for Olema’s OPERA-02 Trial Based on Roche’s Promising Giredestrant Data
9d ago
Midday Fly By: Nvidia reports Q3 beat, Abbott buys Exact Sciences
PremiumThe FlyMidday Fly By: Nvidia reports Q3 beat, Abbott buys Exact Sciences
29d ago
Olema Oncology price target raised to $40 from $20 at Guggenheim
Premium
The Fly
Olema Oncology price target raised to $40 from $20 at Guggenheim
29d ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
29d ago
Olema Oncology announces common stock and warrants offering, no amount given
PremiumThe FlyOlema Oncology announces common stock and warrants offering, no amount given
1M ago
Olema Pharmaceuticals Terminates ATM Prospectus
Premium
Company Announcements
Olema Pharmaceuticals Terminates ATM Prospectus
1M ago
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100